COPD Clinical Trial
What is COPD?
COPD – Chronic Pulmonary Obstructive Disease is a progressive lung disease that obstructs airflow from the lungs. This causes difficulty in breathing over time. Symptoms may include shortness of breath, chronic coughing, or wheezing
About the Study
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Compensation for Time and Travel
Study participants who satisfy applicable requirements – All study related visits, care, tests, and medication will be provided to qualified participants at no cost. Reimbursement for time and travel may be provided. Please contact us for more information as it varies by each study
Who is Eligible to Participate?
- Ages 40 to 80 years at time of enrolment
- Have history of moderate to very severe Physician diagnosed COPD
- Documented treatment with medium or high dose inhaled corticosteroids
This information is not inclusive of the required eligibility criteria.
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.